COMPARISON OF GROWTH PERFORMANCE OF BEEF CALVES FROM DIFFERENT GENETIC STRAINS REARED UNDER ORGANIC CONDITIONs (D. 3.2)

The objective of the present study was to compare growth performance of 15 Danish Holstein bull (DHB) calves, 15 Limousine x Danish Holstein crossbred bull (CB) calves and 15 Limousine x Danish Holstein crossbred heifer (CH) calves reared under organic conditions. Spring-born calves were puchased at private farms and arrived at approximately 20 days of age with an average initial body weight of 52.9, 58.5 and 56.1 kg, (SEM 2.6) for DHB, CB and CH, respectively. Calves were kept indoor until weaning at 3 months of age. Calves were gradually introduced to a grass-silage based ration from 3 to 4 months of age. From 4 to 7 months calves were kept on mix grass pasture of ryegrass and white clover. There were significant differences between treatment groups in terms of average daily gain (ADGP1) during the first summer pasture period, average daily gain (ADGI) during the indoor winter period, and average daily gain (ADGP2) during the second summer pasture period (first 7 weeks). Thus, CB had significantly greater ADG than CH for all three periods with DHB being in between. CB had greater values than DHB and CH in terms of LWP1 144, 140 and 135 (SEM 4) kg, ADGP1 1.15, 1.04 and 0.95 (SEM 0.05) kg/d, LW Indoor 222, 213, and 201 (SEM 5) kg and ADGI 1.06, 1.02 and 0.95 (SEM 0.02) kg/d, LWP2 462, 445 and 414 (SEM 9) kg and ADGP2 1.24, 0.98 and 0.68 (SEM 0.04) kg/d for CB, DHB and CH, respectively. The final live weight were not different between CB and DHB but was significantly lower for CH than DHB and CB (483, 539 and 582 (SEM 8) kg, for CH, DHB and CB, respectively). Overall growth performance across all periods was 13% higher for CB than CH

Gode erfaringer med bonding mellem ammetanter og kalve på Danmarks Kvægforskningscenter

I projektet GrOBEat arbejdes der mod at producere mere bæredygtigt økologisk oksekød, der både kan leve op til forbrugernes stigende krav til dyrevelfærd, biodiversitet og klima, samtidig med at det giver en god spiseoplevelse. En del af projektet går ud på at kalvene skal knyttes til nogle ammetanter og følge dem med ud på græs. Erfaringerne med at koble forsøgskalvene og ammetanterne er beskrevet i denne artikel

Globalisation as a challenge or opportunity for organic farming

During one intensive week in October 2005, the authors were gathered to discuss the impact that globalisation has on the Organic Food Systems and the opportunities that globalisation opens up for developing these systems. The meeting took place as a Ph.D. course under the auspices of the Research School of Organic Farming and Food Systems (SOAR; www.soar.dk). All participants research within Organic Agriculture and Food Production in one way or another

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

Glucagon is secreted from pancreatic a cells, and hypersecretion (hyperglucagonemia) contributes to diabetic hyperglycemia. Molecular heterogeneity in hyperglucagonemia is poorly investigated. By screening human plasma using high-resolution-proteomics, we identified several glucagon variants, among which proglucagon 1-61 (PG 1-61) appears to be the most abundant form. PG 1-61 is secreted in subjects with obesity, both before and after gastric bypass surgery, with protein and fat as the main drivers for secretion before surgery, but glucose after. Studies in hepatocytes and in b cells demonstrated that PG 1-61 dose-dependently increases levels of cAMP, through the glucagon receptor, and increases insulin secretion and protein levels of enzymes regulating glycogenolysis and gluconeogenesis. In rats, PG 1-61 increases blood glucose and plasma insulin and decreases plasma levels of amino acids in vivo. We conclude that glucagon variants, such as PG 1-61, may contribute to glucose regulation by stimulating hepatic glucose production and insulin secretion

Improvements in Glucose Metabolism Early After Gastric Bypass Surgery Are Not Explained by Increases in Total Bile Acids and Fibroblast Growth Factor 19 Concentrations

International audienc

Probiotics and Antibiotics in IBD.

International audienceThe involvement of the gut microbiota in the pathogenesis of IBD is supported by many findings and is thus now commonly acknowledged. The imbalance in the composition of the microbiota (dysbiosis) observed in IBD patients is one of the strongest arguments and provides the rationale for a therapeutic manipulation of the gut microbiota. The tools available to achieve this goal include fecal microbiota transplantation, but antibiotics and probiotics have been the most used one until now. Although antibiotics have shown some efficacy in inducing remission in Crohn's disease (CD) and ulcerative colitis (UC), as well as preventing postoperative relapse in CD, they are not currently recommended for the treatment of IBD except for septic complications, notably because of long-term tolerance and ecological issues. Some probiotics have been shown to be as good as 5-aminosalicylic acid to maintain remission in mild-to-moderate UC, but have been disappointing until now in CD in all tested indications. In pouchitis, antibiotics and probiotics have shown efficacy for inducing and maintaining remission, respectively. Targeting the gut microbiota in IBD is an attractive strategy. Current efforts to better understand the host-microbiota interactions in physiological as well as disease settings might lead to the development of rational-based treatments. © 2014 S. Karger AG, Basel